JESSICA BOBOLA: Open Payments
NPI 1538752597 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,376 in 148 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $286 · 2025 $3,376
Food & beverage: $3,317Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $784 |
| EMD Serono, Inc. | 14 | $306 |
| SK Life Science, Inc. | 15 | $281 |
| UCB, Inc. | 8 | $247 |
| PFIZER INC. | 12 | $204 |
| Neurelis, Inc. | 8 | $183 |
| Lundbeck LLC | 8 | $178 |
| Teva Pharmaceuticals USA, Inc. | 3 | $110 |
| Lilly USA, LLC | 5 | $110 |
| Axsome Therapeutics, Inc. | 3 | $105 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, VALTOCO, REXULTI, Rystiggo, Sunosi, TYSABRI.
Industry payments across RI — which companies pay providers there.
